Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation

Current Medical Research and Opinion

Volumn 31, Issue 12, 2015, Pages 2261-2272

  Kaiser, Karen ^a   Cheng, Wendy Y ^b   Jensen, Sally ^a   Clayman, Marla L ^a,c   Thappa, Andrew ^b   Schwiep, Frances ^b   Chawla, Anita ^b   Goldberger, Jeffrey J ^a   Col, Nananda ^d   Schein, Jeff ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ANALYSIS GROUP   (United States)

^c Health and Social Development Program American Institutes of Research   (United States)

^d Shared Decision Making Resources   (United States)

^e JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Atrial fibrillation; Decision aid; Hemorrhage; Oral anticoagulants; Risk prediction models; Shared decision making; Stroke

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL DECISION MAKING; FEMALE; HUMAN; MALE; MOTIVATION; PATIENT PREFERENCE; PILOT STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SHARED DECISION MAKING; VERY ELDERLY; CHEMICALLY INDUCED; DECISION MAKING; DECISION SUPPORT SYSTEM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RISK FACTOR; STROKE;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; STROKE; WARFARIN;

EID: 84955711373     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2015.1096767     Document Type: Article

References (64)

1. Elwyn G, Laitner S, Coulter A, et al. Implementing shared decision making in the NHS. BMJ 2010;341:c5146
2. Greenes R. Clinical Decision Support: The Road Ahead. Boston, MA: Academic Press, 2011
3. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014;1:CD001431
4. Lee CN, Dominik R, Levin CA, et al. Development of instruments to measure the quality of breast cancer treatment decisions. Health Expect 2010;13:258-72
5. Bensing J. Bridging the gap. The separate worlds of evidencebased medicine and patient-centered medicine. Patient Educ Couns 2000;39:17-25
6. Barry MJ, Edgman-Levitan S. Shared decision making-pinnacle of patientcentered care. N Engl J Med 2012;366:780-1
7. Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ 2007;335:24-7
8. Sheridan SL, Shadle J, Simpson RJ, Pignone MP. The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: A pilot randomized trial. BMC Health Serv Res 2006;6:121
9. Hanson L, Carey T, Caprio A, et al. Improving decision making for feeding options in advanced dementia: A randomized, controlled trial. J Am Geriatrics Soc 2011;59:2009-16
10. Weymiller AJ, Montori VM, Jones LA, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: Statin choice randomized trial. Arch Intern Med 2007;167:1076-82
11. Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid: A randomized trial. Arch Intern Med 2009;169:1560-8
12. Hess EP, Knoedler MA, Shah ND, et al. The chest pain choice decision aid: A randomized trial. Circ Cardiovasc Qual Outcomes 2012;5:251-9
13. Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 2010;181:566-77
14. Harrington J, Noble LM, Newman SP. Improving patients' communication with doctors: A systematic review of intervention studies. Patient Educ Counsel 2004;52:7-16
15. Jamison R, Ross M, Hoopman P, et al. Assessment of postoperative pain management: Patient satisfaction and perceived helpfulness. Clin J Pain 1997;12:229-36
16. Hermoni D, Borkan JM, Pasternak S, et al. Doctor-patient concordance and patient initiative during episodes of low back pain. Br J Gen Pract 2000;50:809-10
17. Montori VM, Shah ND, Pencille LJ, et al. Use of a decision aid to improve treatment decisions in osteoporosis: The osteoporosis choice randomized trial. Am J Med 2011;124:549-56
18. Elwyn G, Kreuwel I, Durand MA, et al. How to develop web-based decision support interventions for patients: A process map. Patient Educ Counsel 2011;82:260-5
19. Flynn D, Ford GA, Stobbart L, et al. A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: Lessons for tool developers. BMC Health Serv Res 2013;13:225
20. Durand MA, Stiel M, Boivin J, Elwyn G. Where is the theory? Evaluating the theoretical frameworks described in decision support technologies. Patient Educ Counsel 2008;71:125-35
21. Thomson R, Robinson A, Greenaway J, et al. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Qual Saf Health Care 2002;11:25-31
22. Elwyn G, O'Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One 2009;4:e4705
23. Coulter A, Stilwell D, Kryworuchko J, et al. A systematic development process for patient decision aids. BMC Med Informat Decis Making 2013;13(Suppl 2):S2
24. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-8
25. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67
26. DiMarco JP, Flaker G, Waldo AL, et al. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:650-6
27. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001;119(1 Suppl):108-21S
28. Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarinassociated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011;58:395-401
29. Thomson RG, Eccles MP, Steen IN, et al. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: Randomised controlled trial. Qual Saf Health Care 2007;16:216-23
30. Nicolai R, Saha S, Schechtel M, Hickam D. Radiofrequency Ablation for Atrial Fibrillation: A Guide for Adults. 2009. Available at: Http://www.effective healthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageactiondisplayproduct&productID348&returnpage. Accessed 1 May 2015
31. Man-Son-Hing M, Laupacis A, O'Connor AM, et al. Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med 2000;15:723-30
32. Pai R, Miller J. Atrial Fibrillation: Which Anticoagulant Should I Take to Prevent Stroke? 2013. Available at: Https://www.healthwise.net/cochranedecisionaid/Content/StdDocument.aspx?DOCHWIDabl2009. Accessed 1 May 2015
33. Hess PL, Mirro MJ, Diener HC, et al. Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012. Am Heart J 2014;168:239-47.e1
34. Karcher R, Berman AE, Gross H, et al. Addressing disparities in stroke prevention for atrial fibrillation: Educational opportunities. Am J Med Qual 2015. [Epub ahead of print]. pii: 1062860615577971
35. Ogilvie IM, Newton N, Welner SA, et al. Underuse of oral anticoagulants in atrial fibrillation: A systematic review. Am J Med 2010;123:638-45 e4
36. Patel AA, Lennert B, Macomson B, et al. Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation. Am Health Drug Benefits 2012;5:291-8
37. Seaburg L, Hess EP, Coylewright M, et al. Shared decision making in atrial fibrillation: Where we are and where we should be going. Circulation 2014;129:704-10
38. Pai R, Miller J. Atrial fibrillation: Should I take an anticoagulant to prevent stroke? 2013. Available at: Https://www.healthwise.net/cochranedecisionaid/Content/StdDocument.aspx?DOCHWIDtx2209. Accessed 1 May 2015
39. NICE. Atrial fibrillation: Medicines to help reduce your risk of a stroke-what are the options? National Institute for Health and Care Excellence (NICE), 2014
40. Elwyn G, O'Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: Online international Delphi consensus process. BMJ 2006;333:417
41. Myers R, Daskalakis C, Kunkel E, et al. Mediated decision support in prostate cancer screening: A randomized controlled trial of decision counseling. Patient Educ Counsel 2011;8:240-6
42. Krueger RA, Casey MA. Focus groups: A practical guide for applied research, 3rd edn. Thousand Oaks, CA: Sage Publications, 2000
43. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70
44. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010;137:263-72
45. You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e531-75S
46. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest 2010;138:1093-100
47. Apostolakis S, Lane DA, Guo Y, et al. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: The AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol 2012;60:861-7
48. Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151:713-19
49. National Clinical Guideline Centre. Atrial Fibrillation: The Management of Atrial Fibrillation. London: National Clinical Guideline Centre, 2014
50. Dzeshka MS, Lane DA, Lip GY. Stroke and bleeding risk in atrial fibrillation: Navigating the alphabet soup of risk-score acronyms (CHADS2, CHA2DS2-VASc, R2CHADS2, HAS-BLED, ATRIA, and more). Clin Cardiol 2014;37:634-44
51. Roldan V, Marin F, Fernandez H, et al. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a 'real-world' population with atrial fibrillation receiving anticoagulant therapy. Chest 2013;143:179-84
52. Caldeira D, Costa J, Fernandes RM, et al. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: A systematic review and meta-analysis. J Intervent Card Electrophysiol 2014;40:277-84
53. Zimetbaum PJ, Thosani A, Yu HT, et al. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med 2010;123:446-53
54. Riva N, Smith DE, Lip GY, Lane DA. Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. Age Ageing 2011;40:653-5
55. Lane DA, Lip GY. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation 2012;126:860-5
56. Chewning B, Bylund CL, Shah B, et al. Patient preferences for shared decisions: A systematic review. Patient Educ Counsel 2012;86:9-18
57. Ryan J, Sysko J. The contingency of patient preferences for involvement in health decision making. Health Care Manag Rev 2007;32:30-6
58. Elwyn G, Frosch D, Thomson R, et al. Shared decision making: A model for clinical practice. J Gen Intern Med 2012;27:1361-7
59. Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol 2000;55:68-78
60. Entwistle VA, Carter SM, Cribb A, McCaffery K. Supporting patient autonomy: The importance of clinician-patient relationships. J Gen Intern Med 2010;25:741-5
61. Sardar P, Chatterjee S, Wu WC, et al. New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: Insights from a meta-analysis and indirect treatment comparisons. PLoS One 2013;8:e77694
62. Coleman CM, Khalaf S, Mould S, et al. Novel oral anticoagulants for DC cardioversion procedures: Utilization and clinical outcomes compared with warfarin. Pacing Clin Electrophysiol 2015. [Epub ahead of print]. doi: 10.1371/journal.pone.0100478
63. Verdecchia P, Angeli F, Lip GY, Reboldi G. Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons. PLoS One 2014;9:e100478
64. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: A nationwide cohort study. Thromb Haemostasis 2012;107:1172-9